ArticleFrontiers in nutrition2026
Prevalence of malnutrition and the appropriateness of nutritional support among patients with hematologic malignancies: a GLIM-based study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malnutrition is common among patients with hematologic malignancies, but there are few clinical studies on disease-specific nutritional characteristics and the appropriateness of nutritional support. Methods: This cross-sectional study included 633 hospitalized patients with hematologic malignancies. Nutritional risk was assessed using the NRS-2002, malnutrition was diagnosed according to GLIM criteria, and the appropriateness of nutritional support was evaluated. Results: 54.0% of patients were at nutritional risk, and 39.0% were diagnosed with malnutrition. Significant heterogeneity was observed across different disease subtypes, with multiple myeloma having the highest prevalence of nutritional risk (66.3%) and leukemia having the highest prevalence of malnutrition (44.9%). Female gender, diabetes, hypertension, elevated C-reactive protein, infection, and low serum albumin levels were independent risk factors associated with malnutrition. Only 15.6% of patients received nutritional support; fewer than one-third of malnourished patients received nutritional intervention, while 7.0% of well-nourished patients received nutritional support without clear indications. Conclusion: There is significant heterogeneity in the nutritional status of hospitalized patients with hematologic malignancies, and a marked mismatch exists between nutritional needs and nutritional support. Disease-specific nutritional management based on the GLIM assessment may improve the appropriateness of nutritional support and optimize clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.